0003-4522 : Empliciti 400 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: | 0003-4522 |
Labeler: | E.r. Squibb & Sons, L.L.C. |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
Application #: | BLA761035 |
Rev. Date: |
NDC Package Codes:
- 0003-4522-11: 1 VIAL, SINGLE‑USE IN 1 CARTON (0003‑4522‑11) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Elotuzumab
Dosage Strength:
- 400 mg
Pharmaceutical Classes:
- Antibodies
- Monoclonal [CS]
- SLAMF7-directed Antibody Interactions [MoA]
- SLAMF7-directed Immunostimulatory Antibody [EPC]
Related Products:
Based on records with the same trade name.- 0003-2291 Empliciti 300 mg Intravenous Injection, Powder, Lyophilized, for Solution by E.r. Squibb & Sons, L.L.C.
NDC QR Code
Scan the QR code below to easily reference this data in the future:![NDC 0003-4522 QR Code](/images/NDC-QR/0003-4522-QR.png)
< Prev: 0003-4223Next: 0003-5150 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.